Use of .alpha.,.alpha.'-dithiobis(.beta.-arylacrylic acid) derivatives to enhance zinc serum and tissue concentrations
US4210664A · kind A · utility
2Cited by
1References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 2, 1979 |
| Grant date | Jul 1, 1980 |
| Priority date | — |
| Expiry date | Mar 2, 1999 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D333/24
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to a novel method for enhancing zinc serum and tissue concentrations which comprises administering a compound of the formula: ##STR1## wherein Z is C.dbd.C, O, S, NH; R is hydrogen, methyl, ethyl, hydroxy, methoxy, ethoxy, chlorine, bromine, fluorine, iodine or trifluoromethyl; and n is 1, 2 or 3.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.